Opioid giant’s tactics to influence doctors

It’s not Purdue Pharma this time but opioid giant Mallinckrodt which sells more than Purdue in the US – it was forced by the courts to publish over 1.3million internal documents which exposed how it sought to reframe concerns about addiction as a phobia and muddle the concept as “pseudoaddiction”, even casting opioids as preventive medicine for pain.